Jillian G. Baker

5.2k total citations · 3 hit papers
56 papers, 3.9k citations indexed

About

Jillian G. Baker is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Animal Science and Zoology. According to data from OpenAlex, Jillian G. Baker has authored 56 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Molecular Biology, 29 papers in Cellular and Molecular Neuroscience and 12 papers in Animal Science and Zoology. Recurrent topics in Jillian G. Baker's work include Receptor Mechanisms and Signaling (44 papers), Neuropeptides and Animal Physiology (24 papers) and Pharmacological Effects and Assays (12 papers). Jillian G. Baker is often cited by papers focused on Receptor Mechanisms and Signaling (44 papers), Neuropeptides and Animal Physiology (24 papers) and Pharmacological Effects and Assays (12 papers). Jillian G. Baker collaborates with scholars based in United Kingdom, Australia and United States. Jillian G. Baker's co-authors include Stephen J. Hill, Christopher G. Tate, Tony Warne, Andrew G. W. Leslie, Patricia C. Edwards, Gebhard F. X. Schertler, R. Moukhametzianov, Ian P. Hall, Richard A. Henderson and María J. Serrano‐Vega and has published in prestigious journals such as Nature, PLoS ONE and Chemical Communications.

In The Last Decade

Jillian G. Baker

51 papers receiving 3.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Structure of a β1-adrenergic G-protein-coupled receptor

2008 1.1k citations Tony Warne, Jillian G. Baker et al. Nature profile →
The structural basis for agonist and partial agonist action on a β1-adrenergic receptor

2011 513 citations Tony Warne, R. Moukhametzianov et al. Nature profile →
The selectivity of β‐adrenoceptor agonists at human β₁‐, β₂‐ and β₃‐adrenoceptors

2010 469 citations Jillian G. Baker British Journal of Pharmacology profile →

Peers

Jillian G. Baker

CMN

RNMI

PHYSI

CTM

Steven J. Charlton United Kingdom

Erin J. Whalen United States

Denise Wootten Australia

Mari R. Candelore United States

Richard A. Bond United States

P. Leff United Kingdom

Philippe Samama United States

L E Limbird United States

Patricia McDonald United States

Magalì Waelbroeck Belgium

Steven J. Charlton United Kingdom

Jillian G. Baker

2.5k ×0.8

1.3k ×0.7

CMN

462 ×0.9

RNMI

704 ×1.7

PHYSI

282 ×0.8

CTM

Citations per year, relative to Jillian G. Baker Jillian G. Baker (= 1×) peers Steven J. Charlton

Countries citing papers authored by Jillian G. Baker

Since Specialization

Citations

This map shows the geographic impact of Jillian G. Baker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jillian G. Baker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jillian G. Baker more than expected).

Fields of papers citing papers by Jillian G. Baker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jillian G. Baker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jillian G. Baker. The network helps show where Jillian G. Baker may publish in the future.

Co-authorship network of co-authors of Jillian G. Baker

This figure shows the co-authorship network connecting the top 25 collaborators of Jillian G. Baker. A scholar is included among the top collaborators of Jillian G. Baker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jillian G. Baker. Jillian G. Baker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Baker, Jillian G., et al.. (2025). Predicting compounds that interact with the 2 known agonist-induced conformations of the human β1-adrenoceptor. Molecular Pharmacology. 107(11). 100081–100081.

Mwasuku, Christine, et al.. (2025). S122 Oestrogen and ER-β: implications for COPD. A86.3–A87.

Baker, Jillian G., Erica K. Sloan, Kevin D. G. Pfleger, et al.. (2024). Pancreatic Ductal Adenocarcinoma, β-blockers, and Antihistamines: A Clinical Trial Is Needed. Function. 6(1). 1 indexed citations

Babu, Sahana Suresh, et al.. (2023). Characterization of human induced pluripotent stems cells: Current approaches, challenges, and future solutions. Biotechnology Reports. 37. e00784–e00784. 11 indexed citations

Baker, Jillian G. & Dominick Shaw. (2023). Asthma and COPD: A Focus on β-Agonists – Past, Present and Future. Handbook of experimental pharmacology. 285. 369–451. 2 indexed citations

Lim, Victor, et al.. (2022). The Isoleucine at Position 118 in Transmembrane 2 Is Responsible for the Selectivity of Xamoterol, Nebivolol, and ICI89406 for the Human β1-Adrenoceptor. Molecular Pharmacology. 103(2). 89–99.

Chevillard, Florent, et al.. (2021). Fragment evolution for GPCRs: the role of secondary binding sites in optimization. Chemical Communications. 57(81). 10516–10519. 5 indexed citations

Baker, Jillian G., Christophe Fromont, Kevin S. J. Thompson, et al.. (2020). Using Esterase Selectivity to Determine the In Vivo Duration of Systemic Availability and Abolish Systemic Side Effects of Topical β-Blockers. ACS Pharmacology & Translational Science. 3(4). 737–748. 4 indexed citations

Gunera, Jakub, Jillian G. Baker, Niek van Hilten, Daniel M. Rosenbaum, & Peter Kolb. (2020). Structure-Based Discovery of Novel Ligands for the Orexin 2 Receptor. Journal of Medicinal Chemistry. 63(19). 11045–11053. 7 indexed citations

10.

Gunera, Jakub, et al.. (2017). Similarity- and Substructure-Based Development of β₂-Adrenergic Receptor Ligands Based on Unusual Scaffolds. ACS Medicinal Chemistry Letters. 8(5). 481–485. 5 indexed citations

11.

Baker, Jillian G. & Robert G. Wilcox. (2016). β-Blockers, heart disease and COPD: current controversies and uncertainties. Thorax. 72(3). 271–276. 50 indexed citations

12.

Baker, Jillian G., et al.. (2013). Impact of Polymorphic Variants on the Molecular Pharmacology of the Two-Agonist Conformations of the Human β1-Adrenoceptor. PLoS ONE. 8(11). e77582–e77582. 6 indexed citations

13.

Warne, Tony, R. Moukhametzianov, Jillian G. Baker, et al.. (2011). The structural basis for agonist and partial agonist action on a β1-adrenergic receptor. Nature. 469(7329). 241–244. 513 indexed citations breakdown →

14.

Baker, Jillian G.. (2008). Antagonist affinity measurements at the Gi-coupled human histamine H3 receptor expressed in CHO cells. BMC Pharmacology. 8(1). 9–9. 14 indexed citations

15.

Baker, Jillian G.. (2005). Evidence for a Secondary State of the Human β3-Adrenoceptor. Molecular Pharmacology. 68(6). 1645–1655. 29 indexed citations

16.

Baker, Jillian G., Ian P. Hall, & Stephen J. Hill. (2004). Temporal Characteristics of cAMP Response Element-Mediated Gene Transcription: Requirement for Sustained cAMP Production. Molecular Pharmacology. 65(4). 986–998. 33 indexed citations

17.

Baker, Jillian G., Ian P. Hall, & Stephen J. Hill. (2003). Influence of Agonist Efficacy and Receptor Phosphorylation on Antagonist Affinity Measurements: Differences between Second Messenger and Reporter Gene Responses. Molecular Pharmacology. 64(3). 679–688. 44 indexed citations

18.

Baker, Jillian G., Ian P. Hall, & Stephen J. Hill. (2003). Pharmacology and direct visualisation of BODIPY‐TMR‐CGP: a long‐acting fluorescent β₂‐adrenoceptor agonist. British Journal of Pharmacology. 139(2). 232–242. 32 indexed citations

19.

Baker, Jillian G., Ian P. Hall, & Stephen J. Hill. (2002). Pharmacological characterization of CGP 12177 at the human β₂‐adrenoceptor. British Journal of Pharmacology. 137(3). 400–408. 39 indexed citations

20.

Baker, Jillian G., et al.. (1994). Chlorpromazine and QX222 block 5-HT3 receptors in N1E-115 neuroblastoma cells. Neuropharmacology. 33(3-4). 493–499. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact